Massimo Breda
Impact in
- Analytical Chemistry top 5%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 4
- Drug Transport and Resistance Mechanisms 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Christopher James (7 shared papers)Christopher James (2 shared papers)Daniela Fraier (2 shared papers)M. Strolin Benedetti (5 shared papers)E. Frigerio (6 shared papers)E. Pianezzola (4 shared papers)Alberto E. Panerai (3 shared papers)Gianfranco Fonte (2 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (8 papers)Chromatographia (3 papers)Journal of Chromatography A (2 papers)Pharmacological Research (2 papers)Analytical and Bioanalytical Chemistry (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Breda
34 papers receiving 669 citations
Peers
Comparison fields: 5 of 90
- Analytical Chemistry 91
- Biomaterials 113
- Spectroscopy 136
- Pharmacology 48
- Oncology 139
Countries citing papers authored by Massimo Breda
This map shows the geographic impact of Massimo Breda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Breda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Breda more than expected).
Fields of papers citing papers by Massimo Breda
This network shows the impact of papers produced by Massimo Breda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Breda. The network helps show where Massimo Breda may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Breda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 104 | |
| 2 | 2005 | 67 | |
| 3 | 2005 | 51 | |
| 4 | 2003 | 42 | |
| 5 | 1991 | 42 | |
| 6 | 2003 | 42 | |
| 7 | 1990 | 39 | |
| 8 | 2010 | 39 | |
| 9 | 2012 | 34 | |
| 10 | 2004 | 31 | |
| 11 | 1996 | 29 | |
| 12 | Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762). | 1995 | 24 |
| 13 | 2017 | 22 | |
| 14 | 2004 | 19 | |
| 15 | 2008 | 19 | |
| 16 | 1993 | 18 | |
| 17 | 1998 | 12 | |
| 18 | 1992 | 12 | |
| 19 | 1999 | 11 | |
| 20 | 1999 | 9 |
About Massimo Breda
Massimo Breda is a scholar working on Oncology, Molecular Biology, Pharmacology, Spectroscopy and Pharmacology, having authored 34 papers that have together received 729 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Biosimilars and Bioanalytical Methods (5 papers), Analytical Chemistry and Chromatography (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Analytical Chemistry (91 citations), Biomaterials (113 citations), Spectroscopy (136 citations), Pharmacology (48 citations) and Oncology (139 citations). Massimo Breda has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Christopher James, Christopher James, Daniela Fraier, M. Strolin Benedetti, E. Frigerio, E. Pianezzola, Alberto E. Panerai, Gianfranco Fonte, Cinzia Pellizzoni and Wilma Barcellini. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Chromatographia, Journal of Chromatography A, Pharmacological Research and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.